Dr. Haruko Yamamoto, a specialist in neurology, is now the Executive Director at the National Cerebral and Cardiovascular Center (NCVC), where she also serves as the Director of the Dept. of Data Science and the Dept. of Clinical Trial Management. She has led several investigator-initiated clinical studies evaluating new drugs and high-risk medical devices. After leading the academic research organization at NCVC for over ten years, she was appointed Chief Medical Officer/ Associate Executive Director at the Pharmaceutical and Medical Devices Agency til 2023. She serves as the chair of the DIA Advisory Council of Japan and a member of the Medical Device Symposium program committee. Dr. Yamamoto holds a PhD in medicine from Osaka University.